Publications
Publications
Show Results For
-
All HBS Web
(230)
- Faculty Publications (44)
Page 1 of
44
Results
→
- March 2023
- Case
On
By: Ramon Casadesus-Masanell, Karolin Frankenberger and Sascha Mader
Founded in 2010, in just one decade, the Swiss company On had established itself as a main player in global sports footwear and apparel. Based on an unconventional strategy which one of the founders labeled as “obsessively distinct,” On grew its sales with a compound...
View Details
- 2022
- Working Paper
Coordination and Incumbency Advantage in Multi-Party Systems: Evidence from French Elections
By: Kevin Dano, Francesco Ferlenga, Vincenzo Galasso, Caroline Le Pennec and Vincent Pons
In theory, free and fair elections can improve the selection of politicians and incentivize them to exert effort. In practice, incumbency advantage and coordination issues may lead to the (re)election of bad politicians. We ask whether these two forces compound each...
View Details
- 2022
- Book
Healthy Buildings: How Indoor Spaces Can Make You Sick—or Keep You Well
By: Joseph G. Allen and John D. Macomber
For too long we’ve designed buildings that haven’t focused on the people inside—their health, their ability to work effectively, and what that means for the bottom line. An authoritative introduction to a movement whose vital importance is now all too clear, Healthy...
View Details
- September 2021
- Article
Joint Problem-solving Orientation in Fluid Cross-boundary Teams
By: Michaela J. Kerrissey, Anna T. Mayo and Amy C. Edmondson
Using interviews, a national field survey, and an online laboratory study, we have examined teamwork in fluid cross-boundary teams. Across three studies, we qualitatively discovered and quantitatively explored "joint problem-solving orientation" as a new team factor....
View Details
- January 2021 (Revised March 2022)
- Case
Into the Raging Sea: Final Voyage of the SS El Faro
By: Joseph B. Fuller and Mel Martin
Captain Michael Davidson of the container ship SS El Faro was determined to make his planned shipping trip on time—but a hurricane was approaching his intended path. To succeed, Davidson and his fellow officers must plot a course to avoid the storm in the face of...
View Details
- Article
Healthy Buildings in 2070
By: John D. Macomber and Joseph G. Allen
Fifty years seems a very long time in the future for most industries. Not so in buildings and real estate; built structures routinely last decades if not hundreds of years, as long as they are economically competitive. Any discussion of the 50-year future has to...
View Details
- September 2020
- Teaching Note
TransDigm in 2017: The Beginning of the End or the End of the Beginning?
By: Benjamin C. Esty and Daniel Fisher
Teaching Note for HBS Case No. 720-422. TransDigm was a highly acquisitive company that manufactured a wide range of highly engineered aerospace parts for both military and commercial customers. Over the ten years ending in 2016, its stock price had increase ten times,...
View Details
Keywords:
Value Capturing;
Pricing Strategy;
Supplier Power;
Buyer Power;
Porter's Five Forces;
Bargaining Power;
Monopoly;
Aerospace;
Acquisition Strategy;
Value Drivers;
Ethical Behavior;
Regulation;
Growth Strategy;
Business Ethics;
Defense;
Procurement;
Sustainability;
Value-Based Business Strategy;
Acquisition;
Ethics;
Private Equity;
Financial Strategy;
Growth Management;
Performance Evaluation;
Business Strategy;
Competitive Strategy;
Horizontal Integration;
Value Creation;
Competitive Advantage;
Aerospace Industry;
Air Transportation Industry;
United States
- June 2020
- Case
Breakthroughs at Blueprint Medicines
By: Richard G. Hamermesh, Kathy Giusti and Susie L. Ma
Precision medicine company Blueprint Medicines was building a successful track record for bringing drug therapies to market 40% faster than average. The company had spent $40 million dollars and two years building a compound library that became its drug development...
View Details
- April 2020 (Revised April 2023)
- Supplement
TransDigm in 2017: The Beginning of the End or the End of the Beginning?
By: Benjamin C. Esty and Daniel Fisher
TransDigm was a highly acquisitive company that manufactured a wide range of highly engineered aerospace parts for both military and commercial customers. Over the ten years ending in 2016, its stock price had increase ten times, and both EBITDA and revenues had grown...
View Details
- April 2020 (Revised April 2023)
- Case
TransDigm in 2017: The Beginning of the End or the End of the Beginning?
By: Benjamin C. Esty and Daniel Fisher
TransDigm was a highly acquisitive company that manufactured a wide range of highly engineered aerospace parts for both military and commercial customers. Over the ten years ending in 2016, its stock price had increased ten times, and both EBITDA and revenues had grown...
View Details
Keywords:
Value Capturing;
Pricing Strategy;
Supplier Power;
Buyer Power;
Porter's Five Forces;
Bargaining Power;
Monopoly;
Aerospace;
Acquisition Strategy;
Value Drivers;
Ethical Behavior;
Regulation;
Growth Strategy;
Business Ethics;
Defense;
Procurement;
Sustainability;
Value-Based Business Strategy;
Acquisition;
Ethics;
Private Equity;
Financial Strategy;
Growth Management;
Performance Evaluation;
Business Strategy;
Competitive Strategy;
Horizontal Integration;
Value Creation;
Competitive Advantage;
Aerospace Industry;
Air Transportation Industry;
United States
- Article
The Role of Interactivity in Local Differential Privacy
By: Matthew Joseph, Jieming Mao, Seth Neel and Aaron Leon Roth
We study the power of interactivity in local differential privacy. First, we focus on the difference between fully interactive and sequentially interactive protocols. Sequentially interactive protocols may query users adaptively in sequence, but they cannot return to...
View Details
- October 2019
- Supplement
Granite Equity Compounding Returns Calculations
By: Victoria Ivashina and Terrence Shu
- June 2019
- Article
Brokers vs. Retail Investors: Conflicting Interests and Dominated Products
By: Mark Egan
I study how brokers distort household investment decisions. Using a novel convertible bond dataset, I find that consumers often purchase dominated bonds—cheap and expensive versions of otherwise identical bonds coexist in the market. The empirical evidence suggests...
View Details
- February 2019
- Teaching Note
Talent@Tencent
By: Tarun Khanna
Late in 2016, two senior human resources (HR) executives at Tencent Holdings (Tencent), China’s leading Internet services firm, are assessing the effectiveness of the company’s talent management practices in responding to Tencent’s sustained hypergrowth. Over the...
View Details
- Spring 2018
- Article
The Enemy of My Enemy: The Soviet Union, East Germany, and the Iranian Tudeh Party's Support for Ayatollah Khomeini
By: Jeremy Friedman
This article examines the strategy of the Iranian Tudeh Party in concert with its Soviet and East German patrons and allies during and after the Iranian revolution of 1979. The article assesses the thinking behind the Tudeh’s strategy of unwavering support for...
View Details
- May 2017
- Teaching Note
Partners Group: Ain't No Mountain High Enough
Partners Group (PG), a Swiss-based PE manager, initiated a series of strategic shifts and evolved from a predominately fund-of-funds manager into a large, multi-asset class PE firm focused on direct investments. PG was the first PE firm to go public in 2006. A number...
View Details
- April 2017
- Case
Imprimis (A)
By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel
This case examines the strategic choices and evolving business model of Imprimis Pharmaceuticals from the perspective of CEO Mark Baum. The (A) case provides a brief history of the company and of the compounding business, outlining the challenges faced by Imprimis in...
View Details
- April 2017
- Supplement
Imprimis (B)
By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel
This case is a supplement to Imprimis (A). It describes the company’s decision to enter into the pharmaceutical compounding business in 2013–2014. Imprimis purchased a compounded ophthalmological medication called Dropless Therapy, which was injected into patients’...
View Details
- April 2017
- Supplement
Imprimis (C)
By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel
This case is a supplement to Imprimis (A & B). Set in 2015, it first describes Imprimis’s decision to introduce its own line of compounded eye drop medication called LessDrops. The case then examines the moral dilemma faced by CEO Mark Baum, who was struck by the...
View Details
- April 2017
- Supplement
Imprimis (D)
By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel
This case is a supplement to Imprimis (A, B, & C). It describes Imprimis’s 2015 decision to develop a $1 per pill compounded alternative to Daraprim, the branded drug that had recently undergone an extreme price hike, raising its price to $750 per pill. Imprimis also...
View Details